Agenus, Inc. (AGEN)
3.42
+0.10
(+3.01%)
USD |
NASDAQ |
May 27, 13:03
Agenus Free Cash Flow : -87.53M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Inovio Pharmaceuticals, Inc. | -83.57M |
| Amarin Corp. Plc | 25.63M |
| Vertex Pharmaceuticals, Inc. | 3.710B |
| Halozyme Therapeutics, Inc. | 667.65M |
| Protalix Biotherapeutics, Inc. | 13.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.95M |
| Cash from Investing (Quarterly) | 68.95M |
| Cash from Financing (Quarterly) | -0.993M |
| Free Cash Flow Per Share (Quarterly) | -0.939 |
| Free Cash Flow to Equity (Quarterly) | -5.515M |
| Free Cash Flow to Firm (Quarterly) | -21.26M |
| Free Cash Flow Yield | -76.07% |